Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen QIAseq cfDNA All-in-One Kit

Qiagen has launched the QIAseq cfDNA All-in-One kit, which combines cell-free DNA extraction and library preparation in the first dedicated solution for liquid biopsy analysis on any next-generation sequencing platform. The kit builds on the company's QIAamp technology and integrates the company's recently launched PAXgene Blood ccfDNA tube for collection and stabilization of blood samples. It creates a streamlined testing solution that allows faster, more convenient, and reliable analysis of cell-free DNA from sample collection to interpreted result, the company said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.